AFTER THE 13th_ELSF FORUM
​​> ATTENDEES
​​> INVESTORS
> PRESENTERS
> RISING STARS
​​> EXHIBITORS
> SPONSORS
​​> SUPPORTERS

ATTENDING COMPANIES IN 2020 INCLUDE:

+ND Capital
4D Lifetec AG
A-LabInsider UG
AbbVie Ventures
AbbVie, Inc.
Abingworth LLP
ACellT (Apeiron Cell Therapies GmbH)
Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
Acticor Biotech SAS
ACXIT Capital Management GmbH
Adrenomed AG
aescuvest international GmbH
Agile Capital Markets
Alibion AG
Alpha Tau Medical Ltd.
ALSA Holdings
Alta Life Sciences
Amadix
Amazon Web Services (AWS)
AmpliVak Immunotherapy GmbH
Amryt Pharma Plc.
Amypopharma S.r.l.
Anagenesis Biotechnologies
Andarix Pharmaceuticals
Anergis SA
Angelini ACRAF S.p.A.
Anima Biotech, Inc.
Anjarium Biosciences AG
Anocca AB
AnRes Clinical
Antabio SAS
Apollo Ventures
Araris Biotech AG
ariadne-service GmbH
ARTIDIS AG
ARTO AG
Arvelle Therapeutics GmbH
Asklepios Advisors
AstraZeneca
Atara Biotherapeutics, Inc.
ATGN Consulting
Athenion AG
ATIcure AG
AUM Biosciences
Aurealis Therapeutics AG
Avectas Ltd.
B3C Group GmbH
Banca del Ceresio
Bank Julius Baer & Co. Ltd.
Banque Profil de Gestion SA
BaseLaunch
BAYOOMED Medical Software
BB Pureos Bioventures
Bellevue Asset Management AG
Beo Therapeutics AG
Bergmann zur Hausen & Cie. GmbH
Berlin Partner for Business and Technology GmbH
BERNINA BioInvest Ltd
BestHealth4U, Unipessoal Lda
Binz Biotech Consulting
BioBac BioValley Business Angel Association
BioGeneration Ventures
BioMedPartners AG
BioPharma Advisory
Biopôle SA
BioScience Managers Pty Ltd.
BioStart Consulting GmbH
BioValley Basel & Suterscience, LLC
Bird & Bird LLP
Bluehaven Therapeutics AG
BlueYard Capital
blufolio SA
Boehler Life Science Advice
Boehringer Ingelheim International GmbH
BOHE Angel Fund
Bone Therapeutics SA
Bootstrap Europe
Boston Pharmaceuticals
Bpifrance
Breslin AG
BROTHERS & PARTNERS EUROPE
Bryan, Garnier & Co
Calypso Biotech SA
Cantabio Pharmaceuticals, Inc.
Capital Grand Est
Capricorn Partners NV
Caribou Biosciences, Inc.
Catalyze B.V.
CD3/CISTIM
Cellestia Biotech AG
Central BioHub GmbH
Cergentis B.V.
Charite
ChinaBio Group
Claris Ventures
Clavis Capital Ltd
ClinGroup
CoFeS China Ltd.
Colpman Consulting Ltd.
Conducta Consulting
Coparion GmbH & Co. KG
Covance, Inc.
Cukierman & Co. Life Sciences
DDF Ventures B.V.
Debere Partners limited
Debiopharm International S.A.
Deepbridge Capital LLP
Delin Ventures Ltd.
Deutsche Bank AG
Digital Networks Plc.
Domain Therapeutics SA
E.Gutzwiller & Cie, Banquiers
EA Pharma Co., Ltd.
Earlybird Venture Capital
Eclosion SA
Edison Investment Research, Inc.
EIT Health e.V.
Eli Lilly and Company
Eligo Bioscience
EMD Serono
Emerging Technology Partners, LLC (ETP)
Emmaus Life Sciences, Inc.
ErfindungsVerwertung AG (EVA)
Ernst & Young AG
ESC Advisors
Euronext
European Investment Bank
European Investment Fund
EVA Basel
Ewopharma AG
F. Hoffmann-La Roche Ltd.
FastVentures B.V.
FineHeart
Forbion
FORESEE Biosystems
Fosun Pharmaceutical AG
Fraser Finance LLP
Free Range Communications GmbH
FreeMind Group
Fund+
FutuRx Ltd.
GAOMA Therapeutics S.A.S.
Genclis SA
GeneLook AG
Genextra S.p.A.
GenSearch Switzerland GmbH
Gilde Healthcare Partners
Gimv
GL Capital Group
Global Biotech Revolution (GBR)
GLSV GmbH
Goetzpartners Securities
Grabulovski Consulting Services GmbH, ex Co-Founder & CSO of Covagen
GrowthCube Partners LLC
H.C. Wainwright & Co., LLC
Hadean Ventures
HalioDx
HBM Partners AG
Headspring Executive Development
Heal Capital
HealthCap
HealthCare Royalty Partners
Helsinn Healthcare SA
Helsinn Investment Fund
HexagonFab Ltd.
Hi-D Imaging AG
High-Tech Gründerfonds Management GmbH
i&i Prague
IAG Italian Angels for Growth
ICF Consult (Switz.)
IGEM Therapeutics Ltd.
Ignite Capital Partners, Inc.
Ihang Equity Investment
iLoF - Intelligent Lab on Fiber
Image Analysis Group
Immunophotonics, Inc.
InCephalo Therapeutics
Indaco Venture Partners SGR SpA
Independed - DO
Independed - SC
Independent - HK
Independent - LB
Independent - LC
Independent - RM
Indicate Solutions
Industrifonden
Infinitum Investors Group
​Inkef Capital B.V.

Innogest Capital
Inositec AG
Inserm Transfert Initiative / Sofimac
Insignals Neurotech
Intel Corp.
Interceptin
Inthera Bioscience AG
Intrepida
Inveready Asset Management
IPDx
IPF Partners
IQVIA Solutions GmbH
ISA Pharmaceuticals B.V.
Italian Institute of Technology
Italian Trade Agency (ITA)
Janssen R&D
Jefferies
Johnson & Johnson Innovation LLC
Johnson & Johnson Innovation – JJDC, Inc.
Joint Polish Investment Fund
Justin Stindt Consulting GmbH
Juvenescence Ltd.
Kempen & Co
KetteRx GmbH
KIZOO Technology Capital GmbH
Koatum
Kreos Capital Management (UK) Ltd.
Kurma Partners
Kuros Biosciences AG
Lancea LLP
LBBW Venture Capital
Life Science Investments & Solutions GmbH
Lifebit Biotech
LifeCare Partners
LifeSci Advisors
LifeSci Capital, LLC
LiMM Therapeutics SA
Lipozyt Marker GmbH
Locust Walk
Lombard Odier
Longliv Ventures, a member of CK Hutchison Holdings
Lonza AG
LSP (Life Sciences Partners)
Lyme Diagnostics Ltd.
Lyonbiopôle
M Ventures
Makwa Ltd
MD Precision Health AG
Medical Simulation Technologies Sp. z o.o.
Medicxi
MedinCell
Memo Therapeutics AG
MercachemSyncom
Merck Healthcare KGaA
Merck KGaA
Metys Pharmaceuticals AG
Microbiotica Ltd.
Microsoft Corporation
Modra Pharmaceuticals B.V.
Momentum Biotech
MOWOOT
MSD
MSQ Ventures
munevo GmbH
Nanoglue
Nature Biotechnology
Neomed
Neuriliv Therapeutics
Neurimmune AG
Neurogenesis Ltd.
New Enterprise Associates (NEA)
Nextech Invest Ltd.
Novaremed AG
Novartis International AG
Novartis Venture Fund
Novasecta Ltd.
Novigenix SA
Novo Holdings A/S
NRW Bank
Numab Therapeutics AG
NxR Biotechnologies GmbH
NZZ
Ochre Bio Ltd.
OCT Group LLC
Octarine Bio
Oddo BHF
Omnes Capital
Optimum Strategic Communications
Optum Ventures
Oryzon Genomics S.A.
Panacea Venture
Panakès Partners SGR SpA
Pantheon Biosciences
PDC*line Pharma SA
Peppermint VenturePartners GmbH
Perseo Pharma AG
PharmaBiome AG
Pharmaleads SA
PharmaVentures Ltd.
Pherecydes Pharma S.A.
Phi Pharma S.A.
Plusimple S.r.l.
Pontifax Venture Capital
PreciHealth SA
Private Investor
Prokarium Ltd.
Proxi Biotech
Raybow Pharmaceutical Co., Ltd.
RBC Capital Markets
RBV Capital
Redalpine Venture Partners AG
RheoDx
Roivant Sciences GmbH
Rosetta Capital Ltd
RSA Consulting Ltd.
Ruffena Capital Ltd.
Russell Reynolds Associates
Salus Partners SA
Sanara Ventures Ltd.
Sanofi
Saverna Therapeutics AG
SCC LifeScience
Schroder Adveq
Schwarz Financial Communication
SciRhom GmbH
SDI @ British Embassy Berne
Serengen GmbH
Seroba Life Sciences
Seventure Partners
Sourcia B.V.
SOUSEIKAI Global Clinical Research Center
STALICLA S.A.
Starpharma Pty Ltd.
Stifel Financial Corp.
Strategic Transactions Advisory AG
Suenos Advisors Est.
Summit Partners Limited
Sunstone Life Science Ventures A/S
Superlab Suisse AG
Swiss Biotech Association
Swiss Tech Capital AG
Syncrosome
Syneos Health
SyNoesis Therapeutics Ltd.
TargImmune Therapeutics AG
The Ark Foundation
The Coulter Partnership S.a.r.l.
The Fulford Group Ltd.
The Janssen Pharmaceutical Companies of Johnson & Johnson
The UK Department for International Trade, British Embassy
TOLREMO Therapeutics AG
Torreya Partners LLP
TruVenturo GmbH
Turos Capital AG
TVM Life Science Management GmbH
Twelve Bio
UCB Ventures
Umblin
Unicyte AG
University of Zurich
Univfy Inc.
V-Bio Ventures
Valor Management S.A.
valuationLAB AG
VAXIMM GmbH
Ventac Partners GmbH
Venture Valuation AG
Versant Ventures
Vesalius Biocapital Partners Sàrl
VI Partners AG
Viopas Partners
Virometix AG
Vivant Holdings
Vogel BioC
WBB Securities, LLC
Wellington Partners
WG Partners LLP
Whale Bay Capital
Wille AG
XENOTHERA
XOventure GmbH
Yafo Capital
Ysios Capital Partners
Zeab Therapeutic Ltd.
ZKB (Zürcher Kantonalbank)
​
​More TBA...

*Updated on 17.02.2020